Harnal (Tamsulosin) Orodispersable CR


Indications and Reactions:

Role Indications Reactions
Primary
Benign Prostatic Hyperplasia 50.3%
Hypertonic Bladder 13.5%
Pollakiuria 4.3%
Dysuria 3.8%
Hypertension 2.7%
Osteoarthritis 2.7%
Product Used For Unknown Indication 2.7%
Prostate Cancer 2.7%
Nocturia 2.2%
Renal Impairment 2.2%
Renal Transplant 2.2%
Dyslipidaemia 1.6%
Rhinitis 1.6%
Angina Pectoris 1.1%
Cerebrovascular Disorder 1.1%
Diabetes Mellitus 1.1%
Hyperlipidaemia 1.1%
Hyperuricaemia 1.1%
Incontinence 1.1%
Residual Urine 1.1%
Urinary Retention 15.7%
Hepatic Function Abnormal 7.2%
Loss Of Consciousness 6.0%
Platelet Count Decreased 6.0%
Dementia 4.8%
Drug Eruption 4.8%
Intervertebral Disc Protrusion 4.8%
Melaena 4.8%
Rhabdomyolysis 4.8%
Vomiting 4.8%
Abdominal Distension 3.6%
Cardio-respiratory Arrest 3.6%
Cerebral Infarction 3.6%
Hyponatraemia 3.6%
Intraocular Pressure Increased 3.6%
Liver Disorder 3.6%
Orthostatic Hypotension 3.6%
Shock 3.6%
Tinnitus 3.6%
Vitamin B12 Deficiency 3.6%
Secondary
Benign Prostatic Hyperplasia 59.5%
Hypertonic Bladder 6.8%
Cerebrovascular Disorder 5.4%
Hyperlipidaemia 5.4%
Hypertension 5.4%
Hyperuricaemia 5.4%
Prostate Cancer 5.4%
Dysuria 4.1%
Drug Use For Unknown Indication 1.4%
Parkinson's Disease 1.4%
Drug Eruption 18.2%
Melaena 18.2%
Rash Papular 12.1%
Vomiting 12.1%
Liver Disorder 6.1%
Asthenia 3.0%
Cardiac Failure 3.0%
Concomitant Disease Progression 3.0%
Dyspnoea 3.0%
Immobile 3.0%
Loss Of Consciousness 3.0%
Marasmus 3.0%
Muscular Weakness 3.0%
Myasthenia Gravis 3.0%
Pneumonia Aspiration 3.0%
White Blood Cell Count Increased 3.0%

Drug Data